Subclinical atherosclerosis in adolescents and young adults and the risk of cardiovascular disease: The Strong Heart Family Study (SHFS)

Jessica A Reese, Mary J Roman, Jason F Deen, Tauqeer Ali, Shelley A Cole, Richard B Devereux, Amanda M Fretts, Barbara V Howard, Elisa T Lee, Kimberly Malloy, Parmanand Singh, Jason G Umans, Ying Zhang, Jessica A Reese, Mary J Roman, Jason F Deen, Tauqeer Ali, Shelley A Cole, Richard B Devereux, Amanda M Fretts, Barbara V Howard, Elisa T Lee, Kimberly Malloy, Parmanand Singh, Jason G Umans, Ying Zhang

Abstract

Background and aims: Rates of cardiovascular disease (CVD) among American Indians (AI) have been increasing. Although we have observed an association between atherosclerosis and CVD in older adults, the potential association among young AI is unclear. Therefore, we aim to describe the prevalence of atherosclerosis among young AI and determine its association with CVD and all-cause mortality.

Methods and results: We evaluated AI participants from the Strong Heart Family Study (SHFS), who were <40 years old and CVD free at the baseline examination, 2001-2003 (n = 1376). We used carotid ultrasound to detect baseline atherosclerotic plaque. We identified CVD events and all-cause mortality through 2019, with a median follow-up of 17.8 years. We used shared frailty Cox Proportional Hazards models to assess the association between atherosclerosis and time to CVD event or all-cause mortality, while controlling for covariates. Among 1376 participants, 71 (5.2%) had atherosclerosis at baseline. During follow-up, 120 (8.7%) had CVD events and 104 (7.6%) died from any cause. CVD incidence was higher in participants who had baseline atherosclerosis (13.51/1000 person-years) than in those who did not (4.95/1000 person-years, p = 0.0003). CVD risk and all-cause mortality were higher in participants with atherosclerosis, while controlling for covariates (CVD HR = 1.85, 95%CI = 1.02-3.37, p = 0.0420; all-cause mortality HR = 2.04, 95%CI = 1.07-3.89, p = 0.0291).

Conclusions: Among young AI, atherosclerosis was independently associated with incident CVD and all-cause mortality later in life. Thus, atherosclerosis begins early in life and interventions in adolescents and young adults to slow the progression of disease could prevent or delay CVD events later in life.

Keywords: Adolescent; American Indian; Atherosclerosis; Cardiovascular disease; Strong Heart Family Study; Young adult.

Copyright © 2022 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. All rights reserved.

Figures

Figure 1:
Figure 1:
CVD free probability for American Indians, ages 14 to

Figure 2:

Survival probability for American Indians,…

Figure 2:

Survival probability for American Indians, ages 14 to <40, with or without atherosclerotic…

Figure 2:
Survival probability for American Indians, ages 14 to
Similar articles
Cited by
References
    1. Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, Howard WJ, Rhoades ER, Robbins DC, Sievers ML and Welty TK. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation. 1999;99:2389–95. - PubMed
    1. Chinali M, de Simone G, Roman MJ, Best LG, Lee ET, Russell M, Howard BV and Devereux RB. Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study. J Am Coll Cardiol. 2008;52:932–8. - PMC - PubMed
    1. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 Suppl 5:S213–56. - PMC - PubMed
    1. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE and Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338:1650–6. - PubMed
    1. McGill HC Jr., McMahan CA, Zieske AW, Sloop GD, Walcott JV, Troxclair DA, Malcom GT, Tracy RE, Oalmann MC and Strong JP. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol. 2000;20:1998–2004. - PubMed
Show all 37 references
Publication types
MeSH terms
Related information
[x]
Cite
Copy Download .nbib .nbib
Format: AMA APA MLA NLM
Figure 2:
Figure 2:
Survival probability for American Indians, ages 14 to

References

    1. Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, Howard WJ, Rhoades ER, Robbins DC, Sievers ML and Welty TK. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation. 1999;99:2389–95.
    1. Chinali M, de Simone G, Roman MJ, Best LG, Lee ET, Russell M, Howard BV and Devereux RB. Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study. J Am Coll Cardiol. 2008;52:932–8.
    1. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 Suppl 5:S213–56.
    1. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE and Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338:1650–6.
    1. McGill HC Jr., McMahan CA, Zieske AW, Sloop GD, Walcott JV, Troxclair DA, Malcom GT, Tracy RE, Oalmann MC and Strong JP. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol. 2000;20:1998–2004.
    1. McGill HC Jr. and McMahan CA. Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am J Cardiol. 1998;82:30t–36t.
    1. Webber BJ, Seguin PG, Burnett DG, Clark LL and Otto JL. Prevalence of and risk factors for autopsy-determined atherosclerosis among US service members, 2001–2011. Jama. 2012;308:2577–83.
    1. Roman MJ, Kizer JR, Best LG, Lee ET, Howard BV, Shara NM and Devereux RB. Vascular Biomarkers in the Prediction of Clinical Cardiovascular Disease. Hypertension. 2012;59:29–35.
    1. Deen JF, Adams AK, Fretts A, Jolly S, Navas-Acien A, Devereux RB, Buchwald D and Howard BV. Cardiovascular Disease in American Indian and Alaska Native Youth: Unique Risk Factors and Areas of Scholarly Need. J Am Heart Assoc. 2017;6.
    1. Chinali M, de Simone G, Roman MJ, Lee ET, Best LG, Howard BV and Devereux RB. Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol. 2006;47:2267–73.
    1. Drukteinis JS, Roman MJ, Fabsitz RR, Lee ET, Best LG, Russell M and Devereux RB. Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: the Strong Heart Study. Circulation. 2007;115:221–7.
    1. De Marco M, de Simone G, Roman MJ, Chinali M, Lee ET, Calhoun D, Howard BV and Devereux RB. Cardiac Geometry and Function in Diabetic or Prediabetic Adolescents and Young Adults: The Strong Heart Study. Diabetes Care. 2011;34:2300–2305.
    1. North KE, Howard BV, Welty TK, Best LG, Lee ET, Yeh JL, Fabsitz RR, Roman MJ and MacCluer JW. Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. Am J Epidemiol. 2003;157:303–14.
    1. Lee ET, Welty TK, Fabsitz R, Cowan LD, Le NA, Oopik AJ, Cucchiara AJ, Savage PJ and Howard BV. The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol. 1990;132:1141–55.
    1. Kauffman SAE, Averill MM, Delaney JAC, Lemaitre RN, Howard BV and Fretts AM. Associations of diet quality and blood serum lipoprotein levels in a population at high risk for diabetes: the Strong Heart Family Study. Eur J Clin Nutr. 2019.
    1. Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG, Rosen S, Alderman MH and Devereux RB. Parallel cardiac and vascular adaptation in hypertension. Circulation. 1992;86:1909–18.
    1. Roman MJ, Pickering TG, Schwartz JE, Pini R and Devereux RB. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. Journal of the American College of Cardiology. 1996;28:751–6.
    1. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, Umans JG and Howard BV. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension. 2007;50:197–203.
    1. Lee ET, Cowan LD, Welty TK, Sievers M, Howard WJ, Oopik A, Wang W, Yeh J, Devereux RB, Rhoades ER, Fabsitz RR, Go O and Howard BV. All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45–74 years, 1984–1988. The Strong Heart Study. American Journal of Epidemiology. 1998;147:995–1008.
    1. Gillum RF, Fortmann SP, Prineas RJ and Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J. 1984;108:150–8.
    1. McKee PA, Castelli WP, McNamara PM and Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441–6.
    1. de Simone G, Devereux RB, Chinali M, Best LG, Lee ET, Galloway JM and Resnick HE. Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population With High Prevalence of Obesity and Diabetes: The Strong Heart Study. Diabetes Care. 2007;30:1851–1856.
    1. Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin BA, Zambon A, Barter P, Fruchart J-C, Eckel RH, Matsuzawa Y and Després J-P. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nature Reviews Endocrinology. 2020;16:177–189.
    1. Halpern A, Mancini MC, Magalhaes ME, Fisberg M, Radominski R, Bertolami MC, Bertolami A, de Melo ME, Zanella MT, Queiroz MS and Nery M. Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment. Diabetol Metab Syndr. 2010;2:55.
    1. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1:S62–9.
    1. Xu J, Knowler WC, Devereux RB, Yeh J, Umans JG, Begum M, Fabsitz RR and Lee ET. Albuminuria within the “normal” range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. Am J Kidney Dis. 2007;49:208–16.
    1. Best LG, Zhang Y, Lee ET, Yeh JL, Cowan L, Palmieri V, Roman M, Devereux RB, Fabsitz RR, Tracy RP, Robbins D, Davidson M, Ahmed A and Howard BV. C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study. Circulation. 2005;112:1289–95.
    1. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr., Taubert K, Tracy RP and Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511.
    1. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W and Howard BV. Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease in Nondiabetic American Indians: The Strong Heart Study. Diabetes Care. 2003;26:861–867.
    1. Lee ET and Wang JW. Statistical Methods for Survival Data Analysis. 3rd ed. Hoboken, New Jersey: John Wiley & Sons, Inc; 2003.
    1. Chen S, Lin J, Matsuguchi T, Blackburn E, Yeh F, Best LG, Devereux RB, Lee ET, Howard BV, Roman MJ and Zhao J. Short leukocyte telomere length predicts incidence and progression of carotid atherosclerosis in American Indians: the Strong Heart Family Study. Aging (Albany NY). 2014;6:414–27.
    1. Valberg M, Grotmol T, Tretli S, Veierod MB, Moger TA and Aalen OO. A hierarchical frailty model for familial testicular germ-cell tumors. American Journal of Epidemiology. 2014;179:499–506.
    1. Mantel N Why Stepdown Procedures in Variable Selection. Technometrics. 1970;12:621–625.
    1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O’Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS, American Heart Association Council on E, Prevention Statistics C and Stroke Statistics S. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139:e56–e528.
    1. Disparities in premature deaths from heart disease−−50 States and the District of Columbia, 2001. MMWR Morb Mortal Wkly Rep. 2004;53:121–5.
    1. Schweigman K, Eichner J, Welty TK and Zhang Y. Cardiovascular disease risk factor awareness in American Indian communities: the strong heart study. Ethn Dis. 2006;16:647–52.
    1. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK and Grp CHSCR. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. New Engl J Med. 1999;340:14–22.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner